Literature DB >> 14996574

Association of peripheral neutrophilia with adverse angiographic outcomes in ST-elevation myocardial infarction.

Ajay J Kirtane1, Anh Bui, Sabina A Murphy, Hal V Barron, C Michael Gibson.   

Abstract

We hypothesized that absolute and relative neutrophilia would be associated with adverse angiographic outcomes in the 394 patient Limitation of Myocardial Infarction Following Thrombolysis in Acute Myocardial Infarction (LIMIT) Acute Myocardial Infarction (AMI) trial of fibrinolysis in ST-elevation myocardial infarction. The mean neutrophil count was 7.9 x 10(9)/L, with a mean neutrophil percentage of 72%. Patients with time from symptom onset to fibrinolytic treatment more than the median (2.7 hours) had a higher neutrophil count and percentage of neutrophils than patients with shorter time to treatment. Patients with a closed infarct-related artery at 90 minutes (Thrombolysis In Myocardial Infarction [TIMI] grade 0/1 flow) had higher neutrophil counts (8.8 +/- 3.8 vs 7.6 +/- 3.0, p = 0.02) but no difference in the percentage of neutrophils than patients with an open artery. Higher neutrophil counts were also mildly correlated with longer corrected TIMI frame counts (CTFC) in the infarct-related artery (r = 0.14, p = 0.02). Patients with impaired myocardial perfusion by TIMI myocardial perfusion grade (TMPG) had a greater percentage of neutrophils (73.2 +/- 10.7% for TMPG 0/1 vs 69.9 +/- 12.6% for TMPG 2/3, p = 0.047) but no detectable difference in neutrophil counts (8.2 +/- 3.3 vs 7.7 +/- 2.9, p = 0.24). There were no significant associations between other indexes in the cell differential and angiographic or clinical outcomes. Higher neutrophil counts remained independently associated with both closed arteries and CTFC in multivariable models controlling for age, left anterior descending artery infarct location, time to treatment, and pulse and blood pressure on admission. A greater percentage of neutrophils remained independently associated with impaired microvascular perfusion in a similar multivariable model. In patients with ST-elevation myocardial infarction, absolute and relative neutrophilia were associated with impaired epicardial and microvascular perfusion.

Entities:  

Mesh:

Year:  2004        PMID: 14996574     DOI: 10.1016/j.amjcard.2003.11.013

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  27 in total

1.  Association of haematological indices with the degree of microvascular injury in patients with acute anterior wall myocardial infarction treated with primary percutaneous coronary intervention.

Authors:  Murat Sezer; Irem Okcular; Taner Goren; Huseyin Oflaz; Yilmaz Nisanci; Berrin Umman; Fehmi Mercanoglu; Ahmet K Bilge; Mehmet Meric; Sabahattin Umman
Journal:  Heart       Date:  2006-08-29       Impact factor: 5.994

2.  Prothrombotic markers and early spontaneous recanalization in ST-segment elevation myocardial infarction.

Authors:  Marie-Geneviève Huisse; Emilie Lanoy; Didier Tcheche; Laurent J Feldman; Annie Bezeaud; Eduardo Anglès-Cano; Murielle Mary-Krause; Dominique de Prost; Marie-Claude Guillin; P Gabriel Steg
Journal:  Thromb Haemost       Date:  2007-08       Impact factor: 5.249

3.  Elevated neutrophil to lymphocyte ratio predicts overall and cardiovascular mortality in maintenance peritoneal dialysis patients.

Authors:  Xin An; Hai-Ping Mao; Xin Wei; Jie-Hui Chen; Xiao Yang; Zhi-Bin Li; Xue-Qing Yu; Zhi-Jian Li
Journal:  Int Urol Nephrol       Date:  2012-10       Impact factor: 2.370

4.  White blood cell subtypes after STEMI: temporal evolution, association with cardiovascular magnetic resonance--derived infarct size and impact on outcome.

Authors:  Oliver Husser; Vicente Bodi; Juan Sanchis; Julio Nunez; Luis Mainar; Francisco Javier Chorro; Maria Pilar Lopez-Lereu; Jose Vicente Monmeneu; Fabian Chaustre; Maria J Forteza; Isabel Trapero; Francisco Dasi; Isabel Benet; Günter A J Riegger; Angel Llacer
Journal:  Inflammation       Date:  2011-04       Impact factor: 4.092

5.  Retention of the NLRP3 Inflammasome-Primed Neutrophils in the Bone Marrow Is Essential for Myocardial Infarction-Induced Granulopoiesis.

Authors:  Gopalkrishna Sreejit; Sunil K Nooti; Andrew J Murphy; Prabhakara R Nagareddy; Robert M Jaggers; Baskaran Athmanathan; Ki Ho Park; Annas Al-Sharea; Jillian Johnson; Albert Dahdah; Man K S Lee; Jianjie Ma
Journal:  Circulation       Date:  2021-11-17       Impact factor: 29.690

6.  Usefulness of Neutrophil to Lymphocyte Ratio in Prediction of Coronary Artery Lesions in Patients with Kawasaki Disease.

Authors:  Fikri Demir; Cem Karadeniz; Rahmi Özdemir; Yılmaz Yozgat; Kübra Çelegen; Utku Karaaslan; Mustafa Demirol; Timur Meşe; Nurettin Ünal
Journal:  Balkan Med J       Date:  2015-10-01       Impact factor: 2.021

7.  Neutrophil-to-Lymphocyte Ratio as a Marker in Patients with Non-arteritic Anterior Ischemic Optic Neuropathy.

Authors:  Onur Polat; Güliz Fatma Yavaş; Sibel İnan; Ümit Übeyt İnan
Journal:  Balkan Med J       Date:  2015-10-01       Impact factor: 2.021

8.  Activatable magnetic resonance imaging agent reports myeloperoxidase activity in healing infarcts and noninvasively detects the antiinflammatory effects of atorvastatin on ischemia-reperfusion injury.

Authors:  Matthias Nahrendorf; David Sosnovik; John W Chen; Peter Panizzi; Jose-Luiz Figueiredo; Elena Aikawa; Peter Libby; Filip K Swirski; Ralph Weissleder
Journal:  Circulation       Date:  2008-02-11       Impact factor: 29.690

9.  Neutrophilia predicts death and heart failure after myocardial infarction: a community-based study.

Authors:  Adelaide M Arruda-Olson; Guy S Reeder; Malcolm R Bell; Susan A Weston; Véronique L Roger
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2009-09-01

10.  Neutrophil to Lymphocyte Ratio Predicts Long-Term Clinical Outcomes in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

Authors:  Yang-Chun Han; Tae-Hyun Yang; Doo-Il Kim; Han-Young Jin; Sang-Ryul Chung; Jeong-Sook Seo; Jae-Sik Jang; Dae-Kyeong Kim; Dong-Kie Kim; Ki-Hun Kim; Sang-Hoon Seol; Dong-Soo Kim
Journal:  Korean Circ J       Date:  2013-02-28       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.